Interested in promotions? | Click here >>
8628
SignalKine™ Human EGF Chemiluminescent Sandwich ELISA Kit
ELISA Kits
ELISA Kit

SignalKine™ Human EGF Chemiluminescent Sandwich ELISA Kit #8628

Citations (0)
No image available
To Purchase # 8628

Important Ordering Details

Custom Ordering Details: Product is assembled to order. Please allow up to three business days for your order to be processed.

Supporting Data

REACTIVITY

Application Key:

  • W-Western
  • IP-Immunoprecipitation
  • IHC-Immunohistochemistry
  • ChIP-Chromatin Immunoprecipitation
  • IF-Immunofluorescence
  • F-Flow Cytometry
  • E-P-ELISA-Peptide

Species Cross-Reactivity Key:

  • H-Human
  • M-Mouse
  • R-Rat
  • Hm-Hamster
  • Mk-Monkey
  • Vir-Virus
  • Mi-Mink
  • C-Chicken
  • Dm-D. melanogaster
  • X-Xenopus
  • Z-Zebrafish
  • B-Bovine
  • Dg-Dog
  • Pg-Pig
  • Sc-S. cerevisiae
  • Ce-C. elegans
  • Hr-Horse
  • All-All Species Expected

Product Description

SignalKine™ Human EGF Chemiluminescent Sandwich ELISA Kit is a solid phase sandwich enzyme-linked immunosorbent assay (ELISA) that detects human EGF (hEGF) in multiple matrices. Unknown samples being tested for hEGF and hEGF standards are added to low volume microwells, where the hEGF is captured by the coated hEGF Rabbit mAb. Following a washing step, a biotinylated hEGF Detection Rabbit mAb is added to detect the captured hEGF. HRP-linked Streptavidin is then used for detection of the biotinylated hEGF Detection Rabbit mAb. A chemiluminescent reagent is added for signal development. The magnitude of light emission, measured in relative light units (RLU) is proportional to the quantity of human EGF in the sample.

SignalKine™ Human EGF Chemiluminescent Sandwich ELISA Kit detects hEGF in multiple matrices that can be quantified by generating a standard curve with the recombinant hEGF protein standard provided. The hEGF standard range is from 0.6 to 2500 pg/ml. Samples containing higher levels of hEGF can be diluted to fit into the standards range.

Background

Epidermal growth factor (EGF) is a small polypeptide hormone that has mitogenic properties in vivo and in vitro, modifying the growth and/or differentiation of many cell types. EGF elicits biologic responses by binding to its cell surface receptor, a transmembrane glycoprotein containing a cytoplasmic protein tyrosine kinase domain (1,2). The binding of EGF to the EGF receptor promotes dimerization of the receptor, autophosphorylation, and activation of downstream signaling components (3). The integrated biological responses to EGF signaling are pleiotropic, including mitogenesis, apoptosis, enhanced cell motility, protein secretion, differentiation, and dedifferentiation. In addition, EGF has been implicated in organ morphogenesis, maintenance, and repair. Moreover, activation of EGF receptor signaling has been correlated with progression to invasion and metastisis in a wide variety of tumors (4-6). Research studies have identified EGF receptor and its downstream signaling molecules as potential targets for therapeutic interventions in wound repair and cancer (4-6).

  1. Wells, A. (1999) Int J Biochem Cell Biol 31, 637-43.
  2. Boulougouris, P. and Elder, J. Anticancer Res 21, 2769-75.
  3. Schlessinger, J. (2002) Cell 110, 669-72.
  4. Sarries, C. et al. (2002) Pharmacogenomics 3, 763-80.
  5. Lorimer, I.A. (2002) Curr Cancer Drug Targets 2, 91-102.
  6. Ghaneh, P. et al. (2002) J Hepatobiliary Pancreat Surg 9, 1-11.

Pathways & Proteins

Explore pathways + proteins related to this product.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST's products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST's Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.